Evidence map›Paper›PMID 22694812›Full record

ArticleMicrobial cell factories2012

Platform for the rapid construction and evaluation of GPCRs for crystallography in Saccharomyces cerevisiae.

Mitsunori Shiroishi, Hirokazu Tsujimoto, Hisayoshi Makyio, Hidetsugu Asada, Takami Yurugi-Kobayashi, Tatsuro Shimamura, Takeshi Murata, Norimichi Nomura, Tatsuya Haga, So Iwata and 1 more

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Activity-restoring mutations in the histamine HProtein science : a publication of the Protein Society · 2026
    Article
  3. Article
  4. Review
  5. Recovery of the histamine HScientific reports · 2023
    Article
  6. Article
  7. Review
  8. State-Targeting Stabilization of Adenosine AInternational journal of molecular sciences · 2021
    Article
  9. Structure of the dopamine DNature communications · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Fluorescent probe for high-throughput screening of membrane protein expression.Protein science : a publication of the Protein Society · 2013
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Mitsunori ShiroishiIwata Human Receptor Crystallography project, ERATO, JST, Kyoto 606-8501, Japan. shiroish@phar.kyushu-u.ac.jp
Hirokazu Tsujimoto
Hisayoshi Makyio
Hidetsugu Asada
Takami Yurugi-Kobayashi
Tatsuro Shimamura
Takeshi Murata
Norimichi Nomura
Tatsuya Haga
So Iwata
Takuya Kobayashi
Kyoto University · JPIwate Biotechnology Research Center · JPGakushuin University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent successes in the determination of G-protein coupled receptor (GPCR) structures have relied on the ability of receptor variants to overcome difficulties in expression and purification. Therefore, the quick screening of functionally expressed stable receptor variants is vital.

resultsWe developed a platform using Saccharomyces cerevisiae for the rapid construction and evaluation of functional GPCR variants for structural studies. This platform enables us to perform a screening cycle from construction to evaluation of variants within 6-7 days. We firstly confirmed the functional expression of 25 full-length class A GPCRs in this platform. Then, in order to improve the expression level and stability, we generated and evaluated the variants of the four GPCRs (hADRB2, hCHRM2, hHRH1 and hNTSR1). These stabilized receptor variants improved both functional activity and monodispersity. Finally, the expression level of the stabilized hHRH1 in Pichia pastoris was improved up to 65 pmol/mg from negligible expression of the functional full-length receptor in S. cerevisiae at first screening. The stabilized hHRH1 was able to be purified for use in crystallization trials.

conclusionsWe demonstrated that the S. cerevisiae system should serve as an easy-to-handle and rapid platform for the construction and evaluation of GPCR variants. This platform can be a powerful prescreening method to identify a suitable GPCR variant for crystallography.

Indexed as

CrystallizationGreen Fluorescent ProteinsHumansPichiaPlasmidsReceptors, G-Protein-CoupledReceptors, Histamine H1Recombinant ProteinsSaccharomyces cerevisiaeGreen Fluorescent ProteinsReceptors, G-Protein-CoupledReceptors, Histamine H1Recombinant Proteins

Identifiers

PMID22694812
PMCPMC3495400
OpenAlexW2128250441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.